Business · 07/02/2023
FDA Renews Cellular, Tissue, and Gene Therapies Advisory Committee for 2 Years
The FDA has renewed the Cellular, Tissue, and Gene Therapies Advisory Committee for an additional 2 years, with the new charter set to expire on October 28, 2024.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →